bioMérieux S.A. (EPA: BIM) Stock Analysis & Fundamentals | ScreenerHero

Create free account

BIMbioMérieux S.A.

EPA · FR · Healthcare · Diagnostics & Research · biomerieux.com

68.70EUR-3.24%Mkt Cap: 8.81B $P/E: 20.571d ago

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It ope…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Cheaper

P/B

Cheaper

Div Yield

Avg

1M Perf

Higher

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap8.81B $

Enterprise Value8.69B $

Revenue (TTM)4.42B $

Gross Profit2.51B $

Net Income (TTM)432.07M $

Revenue/Share37.49 USD

Last Price68.70 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees14.6K

CountryFR

SectorHealthcare

IndustryDiagnostics & Research

ISINFR0013280286

Valuation

P/E (Trailing)20.57

P/E (Forward)14.13

PEG1.31

EV/EBITDA7.08

EV/Revenue1.97

P/S1.99

P/B1.98

EPS (TTM)3.34

EPS (Forward)4.86

52W Range

65.605% of range128.30

52W High128.30 EUR

52W Low65.60 EUR

Profitability

Gross Margin56.73%

Oper. Margin16.81%

EBITDA Margin27.76%

Profit Margin9.77%

ROE9.69%

ROA7.13%

Growth

Revenue Growth-2.50%

Earnings Growth9.40%

Cash Flow & Leverage

Operating CF856.96M $

CapEx (TTM)364.46M $

FCF Margin15.13%

FCF Yield7.60%

Net Debt-117.83M $

Net Debt/EBITDA-0.10

Balance Sheet

Debt/Equity0.11

Current Ratio2.39

Quick Ratio1.42

Book Value/Sh34.77 EUR

Cash/Share4.831 EUR

Dividends

Fwd Div Rate0.9800 EUR

Trail. Div Rate0.9800 EUR

Div. Yield1.40%

5Y Avg Yield0.82%

Payout Ratio26.95%

Ex-Div DateJun 9, 2026

Pay Date—

Splits

Last Split3:1

Split DateSep 20, 2017

Analyst Consensus

Rating2.6 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)84.76 EUR

Upside (mean)+23.4%

Target Range64.00 EUR – 110.00 EUR

€64.00+23.4% to mean€110.00

# Analysts14

Ownership

Shares Out.117.95M

Float40.29M

Insiders66.46%

Institutions18.76%

Technical

SMA 5072.13 (-4.7%)

SMA 20095.63 (-28.2%)

Beta0.56

S&P 52W Chg20.05%

Avg Vol (30d)102.35K

Avg Vol (10d)238.75K

Technical Indicators

RSI (14)43.9

MACD-1.2688

MACD Signal-1.6740

MACD Hist.+0.4053

BB Upper73.32 EUR

BB Middle69.47 EUR

BB Lower65.63 EUR

BB Width11.07%

ATR (14)1.833 EUR

Vol Ratio (20d)3.16x